trial · primary record
Gene Therapy
SMARD1
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2030-07 |
| Primary endpoint | Monitoring for the development of unacceptable toxicity. |
| Registry ID | NCT05152823 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:50.968Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05152823
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.